ASTRAZENECA PLC (AZN)
Clinical trial NCT05850234 updates: 1. completion date: 2028-11-14 → 2029-01-25 2. primary completion date: 2027-08-31 → 2027-10-01 3. enrollment: 182 → 232 participants
Clinical trial NCT05850234 updates: 1. completion date: 2028-11-14 → 2029-01-25 2. primary completion date: 2027-08-31 → 2027-10-01 3. enrollment: 182 → 232 participants
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical